No payment accepted from any clinic or pharmacy listed. No referral fees, no coupon codes, no partnerships.How we make money
Back to the index
Clinic file

GOAL.MD

Reviewed by Editorial review in progress · Last updated 2026-07-12

The bottom line

No verdict has been issued yet.

This is a neutral factual record. GOAL.MD (goal.md) is a direct-to-consumer telehealth brand owned by Jellyfish, LLC (10646 Baptist Church Rd, Saint Louis, MO 63128-1418; business started 11/19/2019; BBB-accredited since 7/13/2021 with an A+ rating), a veteran-owned Missouri company that also operates the brands 420ID.com and Wingman.md and reports 35,000+ members. Its Chief Physician and Co-Founder is Dr. Ted Mimlitz; William B. Phillips is Managing Partner. It sells compounded semaglutide ($149 first month, then $199/mo; a micro-dose variant at $147 then $197/mo), compounded tirzepatide ($249 first month, then $299/mo), a 'GLP-1 Synergy' semaglutide-plus-tirzepatide combination ($597/mo, or $547/mo on a 3-month bundle), and a Brand-Name Access program ($95/mo physician fee plus pharmacy medication cost, roughly $244-$544/mo all-in) fulfilled through NovoCare/TrumpRx (Ozempic, Wegovy) and LillyDirect (Zepbound). Intake is an online health questionnaire with same-day physician review and no appointment required. Compounding pharmacy partners are not disclosed by name. All-50-state coverage appears in third-party search descriptions but was not confirmed as an explicit statement on the pages reviewed, so it is recorded as not confirmed. The company markets 'No auto-billing' prominently, while its own Terms describe recurring monthly auto-billing for the Brand-Name program, and its billing policy states refunds are not issued once payment is processed; these tensions are recorded as red flags below. A Trustpilot profile exists; its figures were not retrievable as of the access date. The BBB profile indicates 1 alert whose text was not retrievable, plus 2 complaints closed in the last 3 years. No FDA action, lawsuit, or state attorney general action specific to GOAL.MD or Jellyfish, LLC was located as of the access date.

The supply chain

You buy fromGOAL.MDThe brand: marketing, checkout, and the subscription.
Your clinician works forGOAL.MDNo contract medical group found on the clinic's own pages.
Your prescription is filled byNo pharmacy on our recordNothing we can verify — the receipt the rest of the chain depends on.
Licensed where you live?Check your stateEvery fill depends on the pharmacy holding a license in your state — verified below, state board by state board.

What checks out

No gate criteria passed yet.

What to watch

Compounded-medication orders cannot be cancelled, modified, or reversed once payment has been processed, and "Refunds will not be issued for any finalized order" — adverse reactions are handled case-by-case with no automatic refund.
GOAL.MD sells 'GLP-1 Synergy,' a compounded semaglutide-plus-tirzepatide combination protocol at $597/mo (or $547/mo bundled), marketed as 'GLP-1 + GIP Combined.' No FDA-approved product combines these two drugs, and pharmacist-reviewed drug-information sources advise against taking semaglutide and tirzepatide together: the drugs act on overlapping incretin pathways, the combination lacks clinical-trial safety and efficacy evidence, and stacking may raise the risk of adverse effects (nausea, vomiting, hypoglycemia) without established added benefit. This is a company-specific product choice — most compounded GLP-1 telehealth competitors do not sell a sema-plus-tirz combination — recorded here as a clinical-practice concern signal, not a verdict.
GOAL.MD's marketing repeatedly claims 'No auto-billing — we ask before every renewal' and its About page says 'No auto-billing or subscriptions,' but its own Terms & Conditions describe the Brand-Name Access program as '$95.00 USD per month, billed in advance' via 'recurring monthly auto-billing' on a fixed monthly Anchor Date, requiring at least 48 hours' notice before the next billing date to cancel, with charges 'final and non-refundable' once processed and clinical work has begun. The no-auto-billing claim is accurate for the compounded plans as described (day-21 check-in, patient approves each order), but as a storewide marketing message it is contradicted by the company's own brand-name program terms.
GOAL.MD's billing policy states that refunds are not issued on compounded-medication orders: orders 'cannot be cancelled, modified, or reversed once payment has been processed,' on the stated rationale that payment triggers immediate non-reversible physician, pharmacy, and shipping work. There is no money-back guarantee or trial window disclosed (contrast with competitors that offer first-month guarantees). A December 2025 BBB complaint shows this policy in dispute in practice: a patient reporting medication quality concerns (lumps in the vial) was denied a refund after a disputed return process; the complaint closed as 'Answered' rather than 'Resolved.'
Trustpilot review integrity
Clean review record
78% of this company's reviews are verified or invited (post-transaction) — only 22% are unprompted, well within our 40% threshold.
Score
4.8 / 5 across 77 reviews (trailing 12 months)
Review source
22% organic (unprompted) · 78% verified or invited (company-sent, post-transaction)
OrganicVerified / invited
Source: Trustpilot's own "Transparent Inviting" disclosure, company profile (accessed 2026-07-12).
Corporate address transparency
Lists a real-looking operating address
Appears to be a real operating address, found on its BBB profile. The company does not publish this address on its own public pages.
Legal entity
Jellyfish, LLC (dba GOAL.MD)
Listed address
10646 Baptist Church Rd, Saint Louis, MO 63128
Notes
Real St. Louis operation with a local phone number; the site itself names the entity but omits the street address.
Source: BBB Business Profile, Jellyfish LLC (accredited; St. Louis MO) (accessed 2026-07-19)

Who fills your prescription

GOAL.MD does not name its compounding pharmacy partners anywhere located as of the access date (homepage, GLP-1 treatment pages, Terms & Conditions, and billing pages were all reviewed). Its pages state only that compounded medications are 'personalized formulations prepared by licensed U.S. 503A or 503B compounding pharmacies' and reference 'independent licensed pharmacy partners' generically, with a 'Compounded in USA' footer note. For its separate Brand-Name Access program, fulfillment is not via a compounding pharmacy at all: Ozempic and Wegovy route through NovoCare/TrumpRx coupons redeemed at a local pharmacy, and Zepbound (vial and KwikPen) routes through LillyDirect with home delivery or Walmart pickup.

Partner pharmacies have not yet been profiled. Each named partner must clear the pharmacy gate independently before this clinic stays on the index.

What it's actually like

Pricing (per goal.md and its GLP-1 treatment pages): compounded semaglutide at $149 for the first month then $199/mo, with a 'Semaglutide Micro-Dose' variant at $147 then $197/mo; compounded tirzepatide at $249 for the first month then $299/mo; and 'GLP-1 Synergy,' a semaglutide-plus-tirzepatide combination, at $597/mo single or $547/mo with a 3-month bundle. A 3-month bundle brings compounded GLP-1 pricing to 'from $177/mo.' The Brand-Name Access program charges a $95/mo physician fee (promotional first month $45) covering the monthly prescription, 'anytime physician access,' and unlimited 1:1 nutrition coaching sessions; medication cost is paid on top, for stated totals of roughly $244/mo (Ozempic pill 1.5mg) to $544/mo (Zepbound 12.5mg/15mg). Ozempic and Wegovy route through NovoCare/TrumpRx coupons redeemed at a local pharmacy; Zepbound routes through LillyDirect with home delivery or Walmart pickup. A 'Medicare Bridge' option is advertised at 'as little as $50/month.' The site also sells non-GLP-1 products (Bella capsules, sermorelin, NAD+, B12, oxytocin, metformin, rapamycin, and others). Intake: a three-step flow — choose a treatment, complete a health questionnaire reviewed the same day by a physician ('Same-day physician approval,' 'No appointment needed to get started'), then medication ships in discreet packaging; the company states board-certified physicians develop and supervise every treatment plan. Pharmacy chain: compounding partners are not named anywhere reviewed; pages say only 'licensed U.S. 503A or 503B compounding pharmacies.' States: no explicit state list or all-50 statement was found on the pages reviewed, so nationwide coverage is recorded as not confirmed (third-party search descriptions assert 50-state service, but the claim could not be confirmed on the site itself as of the access date). Billing/refund/cancel: the company heavily markets 'No auto-billing — we ask before every renewal' for compounded plans, describing a care-team check-in around day 21 where the patient must actively approve the next order; no cancellation notice is required for compounded plans. However, the Brand-Name program is explicitly recurring: $95/mo 'billed in advance' as 'recurring monthly auto-billing' on a fixed monthly 'Anchor Date,' cancellable anytime with at least 48 hours' notice before the next billing date, and 'final and non-refundable' once a monthly charge is processed and clinical work has begun. The billing policy states refunds are not issued on compounded orders: orders 'cannot be cancelled, modified, or reversed once payment has been processed,' on the rationale that medications are custom-compounded and payment triggers 'a series of immediate, non-reversible actions' across physician review, pharmacy work, and shipping. Governing law and arbitration: no governing-law clause, arbitration clause, or class-action waiver was located in the Terms & Conditions as reviewed (recorded as not located as of the access date, not as confirmed absent — the page may render additional content client-side). Corporate record: Jellyfish, LLC, 10646 Baptist Church Rd, Saint Louis, MO 63128-1418 (second location at 1062 Old Des Peres Rd, Des Peres, MO), business started 11/19/2019, BBB-accredited since 7/13/2021, A+ rating, 6 years in business, alternate names GOAL.MD, 420ID/420 ID, and Wingman.MD; the About page states the company was founded in 2019, is veteran-owned, and has served 35,000+ members. The BBB profile indicates '1 alert,' whose text was not retrievable through the profile or complaints pages as of the access date, and shows 2 complaints closed in the last 3 years (both in the last 12 months, both marked 'Answered' rather than 'Resolved'): a March 2026 sales/advertising complaint about a $150 medical-marijuana physician referral under the 420ID brand, and a December 2025 delivery complaint involving medication quality concerns and a disputed refund. Third-party review presence: a Trustpilot profile exists at trustpilot.com/review/goal.md (its score and review counts were not retrievable as of the access date). No FDA warning letter, recall, lawsuit, or attorney general action naming GOAL.MD or Jellyfish, LLC was located as of the access date; 'best GLP-1 telehealth' listicles mentioning GOAL.MD (healingmaps.com, vaccinealliance.org, rollingstone.com product-recommendation pages) were treated as marketing/affiliate content, not independent records.

GOAL.MD in your state

Ship-to coverage per our record, and the state-by-state read: whether GOAL.MD's partner pharmacies hold a license where you live, checked against each state board's own portal. Click any state for its file.

Alaska — Ship-to coverage in reviewAlabama — Ship-to coverage in reviewArkansas — Ship-to coverage in reviewArizona — Ship-to coverage in reviewCalifornia — Ship-to coverage in reviewColorado — Ship-to coverage in reviewConnecticut — Ship-to coverage in reviewDelaware — Ship-to coverage in reviewFlorida — Ship-to coverage in reviewGeorgia — Ship-to coverage in reviewHawaii — Ship-to coverage in reviewIowa — Ship-to coverage in reviewIdaho — Ship-to coverage in reviewIllinois — Ship-to coverage in reviewIndiana — Ship-to coverage in reviewKansas — Ship-to coverage in reviewKentucky — Ship-to coverage in reviewLouisiana — Ship-to coverage in reviewMassachusetts — Ship-to coverage in reviewMaryland — Ship-to coverage in reviewMaine — Ship-to coverage in reviewMichigan — Ship-to coverage in reviewMinnesota — Ship-to coverage in reviewMissouri — Ship-to coverage in reviewMississippi — Ship-to coverage in reviewMontana — Ship-to coverage in reviewNorth Carolina — Ship-to coverage in reviewNorth Dakota — Ship-to coverage in reviewNebraska — Ship-to coverage in reviewNew Hampshire — Ship-to coverage in reviewNew Jersey — Ship-to coverage in reviewNew Mexico — Ship-to coverage in reviewNevada — Ship-to coverage in reviewNew York — Ship-to coverage in reviewOhio — Ship-to coverage in reviewOklahoma — Ship-to coverage in reviewOregon — Ship-to coverage in reviewPennsylvania — Ship-to coverage in reviewRhode Island — Ship-to coverage in reviewSouth Carolina — Ship-to coverage in reviewSouth Dakota — Ship-to coverage in reviewTennessee — Ship-to coverage in reviewTexas — Ship-to coverage in reviewUtah — Ship-to coverage in reviewVirginia — Ship-to coverage in reviewVermont — Ship-to coverage in reviewWashington — Ship-to coverage in reviewWisconsin — Ship-to coverage in reviewWest Virginia — Ship-to coverage in reviewWyoming — Ship-to coverage in review
Coverage in review

How we review. Every clinic must clear two gates: a credible compounding pharmacy, licensed in every state it ships to, and a clinic that supports long-term patient success. We pay for our own access and accept no payment, referral fees, or coupon arrangements from anyone we cover. See the methodology.